Search
cbdMD Inc
YCBDAdd to Watchlist
0.509USD
+0.038+8.05%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.12MMarket Cap
0.02P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of cbdMD Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 2.00, with a high of 2.00 and a low of 2.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.000
Target Price
+309.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
cbdMD Inc
YCBD
1
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is cbdMD Inc's expected revenue for the next quarter?
cbdMD Inc's expected revenue is 5.69M.
What is cbdMD Inc's price target?
Analysts forecast that cbdMD Inc's price target is USD 2.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 2.00.
How have cbdMD IncYCBD's recent earnings per share performed?
The market expectation was USD -0.08, while cbdMD IncYCBD's earnings per share (EPS) for the previous quarter was USD -0.04. EPS for the next quarter is expected at USD -0.03.
What is the analyst rating for cbdMD Inc?
Based on the ratings of cbdMD Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.